Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Samar H. Abbas, Amer Ali Abd El-Hafeez, Mai E. Shoman, Monica M. Montano & Heba A. Hassan. (2019) New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity. Bioorganic Chemistry 82, pages 360-377.
Crossref
Crossref
Mixue Xie, Apeng Yang, Jiexian Ma, Min Wu, Hongyue Xu, Kefei Wu, Youxin Jin & Yanhui Xie. (2019) Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal. Cell Death & Disease 9:10.
Crossref
Crossref
Hongying Zhao, Jianjun Xu, Yu Wang, Rongke Jiang, Xue Li, Lili Zhang & Yingqi Che. (2018) Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB. Surgical Oncology 27:3, pages 495-502.
Crossref
Crossref
Yiliang Wang, Fujun Jin, Rongze Wang, Feng Li, Yanting Wu, Kaio Kitazato & Yifei Wang. (2017) HSP90: a promising broad-spectrum antiviral drug target. Archives of Virology 162:11, pages 3269-3282.
Crossref
Crossref
Ondrej Havranek, Jingda XuStefan KöhrerZhiqiang WangLisa BeckerJustin M. ComerJared HendersonWencai MaJohn Man Chun MaJason R. WestinDipanjan GhoshNicholas ShinnersLuhong SunAllen F. YiAnusha R. KarriJan A. BurgerTomasz Zal & R. Eric Davis. (2017) Tonic B-cell receptor signaling in diffuse large B-cell lymphoma. Blood 130:8, pages 995-1006.
Crossref
Crossref
V Atsaves, R Zhang, D Ruder, Y Pan, V Leventaki, G Z Rassidakis & F X Claret. (2015) Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism. Leukemia 29:11, pages 2162-2172.
Crossref
Crossref
Manbok Kim, Masmudur M. Rahman, Christopher R. Cogle & Grant McFadden. (2015) Prevention of EBV lymphoma development by oncolytic myxoma virus in a murine xenograft model of post-transplant lymphoproliferative disease. Biochemical and Biophysical Research Communications 462:4, pages 283-287.
Crossref
Crossref
Jing Wang, Ruixia Liu, Haiyu Qi, Yan Wang, Lijian Cui, Yan Wen, Huihui Li & Chenghong Yin. (2015) The ACE2-Angiotensin-(1–7)-Mas Axis Protects Against Pancreatic Cell Damage in Cell Culture. Pancreas 44:2, pages 266-272.
Crossref
Crossref
Mohitkumar R Gangwani, Richard J NoelJrJr, Ankit Shah, Vanessa Rivera-Amill & Anil Kumar. (2013) Human immunodeficiency virus type 1 viral protein R (Vpr) induces CCL5 expression in astrocytes via PI3K and MAPK signaling pathways. Journal of Neuroinflammation 10:1.
Crossref
Crossref
Zi-Zhen Xu, Zu-Guang Xia, Ai-Hua Wang, Wen-Fang Wang, Zhi-Yin Liu, Li-Yun Chen & Jun-Min Li. (2013) Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab. Annals of Hematology 92:10, pages 1351-1358.
Crossref
Crossref
Hongyan Lv, Yan Li, Hengfei Du, Jie Fang, Xiaoning Song & Jinqiao Zhang. (2013)
The Synthetic Compound Norcantharidin Induced Apoptosis in Mantle Cell Lymphoma In Vivo and In Vitro through the PI3K-Akt-NF-
κ
B Signaling Pathway
. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-11.
Crossref
Crossref
Agata M. Bogusz, Richard H.G. Baxter, Treeve Currie, Papiya Sinha, Aliyah R. Sohani, Jeffery L. Kutok & Scott J. Rodig. (2012) Quantitative Immunofluorescence Reveals the Signature of Active B-cell Receptor Signaling in Diffuse Large B-cell Lymphoma. Clinical Cancer Research 18:22, pages 6122-6135.
Crossref
Crossref
Lapo Alinari, Beth Christian & Robert A. Baiocchi. (2012) Novel targeted therapies for mantle cell lymphoma. Oncotarget 3:2, pages 203-211.
Crossref
Crossref
Bjoern Chapuy, Nikolai Schuelper, Melanie Panse, Andrea Dohm, Elisabeth Hand, Roland Schroers, Lorenz Truemper & Gerald G. Wulf. (2011) Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non-Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylation. British Journal of Haematology 152:4, pages 401-412.
Crossref
Crossref
Seong-Su Han, Hwakyung Yun, Dong-Ju Son, Van S. Tompkins, Liangping Peng, Seung-Tae Chung, Joong-Su Kim, Eun-Sung Park & Siegfried Janz. (2010) NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma. Molecular Cancer 9:1.
Crossref
Crossref
Sverker Hasselblom, Ulrika Hansson, Markus Olsson, Leif Torén, Anders Bergström, Herman Nilsson-Ehle & Per-Ola Andersson. (2010) High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. British Journal of Haematology 149:4, pages 560-568.
Crossref
Crossref
Roman A. Timakhov, Yinfei Tan, Mamta Rao, Zemin Liu, Deborah A. Altomare, Jianming Pei, David L. Wiest, Olga O. Favorova, Janice E. Knepper & Joseph R. Testa. (2009) Recurrent chromosomal rearrangements implicate oncogenes contributing to T‐cell lymphomagenesis in Lck‐MyrAkt2 transgenic mice. Genes, Chromosomes and Cancer 48:9, pages 786-794.
Crossref
Crossref
Qing Wu, Yan Chen, Guohui Cui & Yiquan Cheng. (2009) Wortmannin inhibits K562 lukemic cells by regulating PI3k/Akt channel in vitro. Journal of Huazhong University of Science and Technology [Medical Sciences] 29:4, pages 451-456.
Crossref
Crossref
Dana S. Levy, Jason A. Kahana & Rakesh Kumar. (2009) AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines. Blood 113:8, pages 1723-1729.
Crossref
Crossref
Kun Nie, Jian-Chun Yu, Yu Fu, Hai-Yan Cheng, Fu-Yan Chen, You Qu & Jing-Xian Han. (2009) Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus. Biochemical and Biophysical Research Communications 378:1, pages 103-107.
Crossref
Crossref
Viktor Shtilbans, Maoxin Wu & David E. Burstein. (2008) Current overview of the role of Akt in cancer studies via applied immunohistochemistry. Annals of Diagnostic Pathology 12:2, pages 153-160.
Crossref
Crossref
Yinfei Tan, Roman A. Timakhov, Mamta Rao, Deborah A. Altomare, Jinfei Xu, Zemin Liu, Qingshen Gao, Suresh C. Jhanwar, Antonio Di Cristofano, David L. Wiest, Janice E. Knepper & Joseph R. Testa. (2008)
A Novel Recurrent Chromosomal Inversion Implicates the Homeobox Gene
Dlx5
in T-Cell Lymphomas from Lck-Akt2 Transgenic Mice
. Cancer Research 68:5, pages 1296-1302.
Crossref
Crossref
YK Jeon, CH Park, K‐Y Kim, YC Li, J Kim, YA Kim, J‐H Paik, B‐K Park, C‐W Kim & Y‐N Kim. (2007) The heat‐shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein–Barr virus‐positive NK/T‐cell lymphoma by Akt down‐regulation. The Journal of Pathology 213:2, pages 170-179.
Crossref
Crossref
Hoon Han, Sung-Won Shin, Chi-Yeon Seo, Hyuk-Chan Kwon, Jin-Yeong Han, In-Hoo Kim, Jong-Young Kwak & Joo-In Park. (2007) 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. Apoptosis 12:11, pages 2101-2114.
Crossref
Crossref
Martina RudeliusStefania PittalugaSatoshi NishizukaTrinh H.-T. PhamFalko FendElaine S. JaffeLeticia Quintanilla-MartinezMark Raffeld. (2006) Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 108:5, pages 1668-1676.
Crossref
Crossref